Transcription of CHMP ASSESSMENT REPORT FOR Ellaone
{{id}} {{{paragraph}}}
Example: bankruptcy
CHMP ASSESSMENT REPORT FOR Ellaone
European Medicines Agency Evaluation of Medicines for Human Use 7 Westferry Circus, Canary Wharf, London, E14 4HB, UK Tel. (44-20) 74 18 84 00 Fax (44-20) 75 23 70 51 E-mail: : EMEA/261787/2009 CHMP ASSESSMENT REPORT FOR Ellaone International Nonproprietary Name: ulipristal acetate Procedure No. EMEA/H/C/001027 ASSESSMENT REPORT as adopted by the CHMP with all information of a commercially confidential nature deleted. 2/49 TABLE OF CONTENTS 1. BACKGROUND INFORMATION ON THE PROCEDURE .. 3 Submission of the dossier .. 3 Steps taken for the ASSESSMENT of the 3 2.
5/49 The National Institute of Child Health and Human Development (NICHD) initiated the clinical development phase of ulipristal acetate for use as an emergency contraception.
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: